发明名称 PYRAZOLOPYRIMIDINE COMPOUND
摘要 <p>Provided is a pyrazolopyrimidine compound represented by formula (I) having an HIF-PHD inhibitory effect, or a pharmaceutically acceptable salt thereof. [In the formula, AA indicates an optionally substituted 7-hydroxypyrazolo[4,3-d]pyrimidine-5-yl, X indicates a simple bond or an optionally substituted straight-chain alkylene, Z indicates hydrogen atom, or formula (i), formula (ii) or formula (iii), and rings A and A' are independently an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted alicyclic hydrocarbon, or an optionally substituted non-aromatic heterocycle.]</p>
申请公布号 WO2014030716(A1) 申请公布日期 2014.02.27
申请号 WO2013JP72461 申请日期 2013.08.22
申请人 MITSUBISHI TANABE PHARMA CORPORATION 发明人 NAKAJIMA, TATSUO;GOI, TAKASHI;KAWATA, ATSUSHI;SUGAHARA, MASAKATSU;YAMAKOSHI, SHUHEI
分类号 C07D487/04;A61K31/519;A61P3/10;A61P7/02;A61P7/06;A61P9/10;A61P25/14;A61P25/16;A61P25/28;A61P43/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址